322 related articles for article (PubMed ID: 11850706)
1. Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation.
Hölttä P; Alaluusua S; Saarinen-Pihkala UM; Wolf J; Nyström M; Hovi L
Bone Marrow Transplant; 2002 Jan; 29(2):121-7. PubMed ID: 11850706
[TBL] [Abstract][Full Text] [Related]
2. Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children.
Hölttä P; Alaluusua S; Saarinen-Pihkala UM; Peltola J; Hovi L
Cancer; 2005 Jan; 103(1):181-90. PubMed ID: 15540242
[TBL] [Abstract][Full Text] [Related]
3. Disturbed root development of permanent teeth after pediatric stem cell transplantation. Dental root development after SCT.
Hölttä P; Hovi L; Saarinen-Pihkala UM; Peltola J; Alaluusua S
Cancer; 2005 Apr; 103(7):1484-93. PubMed ID: 15739206
[TBL] [Abstract][Full Text] [Related]
4. Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation.
Hovi L; Saarinen-Pihkala UM; Vettenranta K; Lipsanen M; Tapanainen P
Bone Marrow Transplant; 1999 Nov; 24(10):1131-6. PubMed ID: 10578163
[TBL] [Abstract][Full Text] [Related]
5. Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology.
Flandin I; Hartmann O; Michon J; Pinkerton R; Coze C; Stephan JL; Fourquet B; Valteau-Couanet D; Bergeron C; Philip T; Carrie C
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1424-31. PubMed ID: 16427213
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of bone marrow transplantation on dental status in children with leukaemia.
Uderzo C; Fraschini D; Balduzzi A; Galimberti S; Arrigo C; Biagi E; Pignanelli M; Nicolini B; Rovelli A
Bone Marrow Transplant; 1997 Nov; 20(10):865-9. PubMed ID: 9404928
[TBL] [Abstract][Full Text] [Related]
7. Disturbances in the oral cavity in pediatric long-term survivors after different forms of antineoplastic therapy.
Näsman M; Björk O; Söderhäll S; Ringdén O; Dahllöf G
Pediatr Dent; 1994; 16(3):217-23. PubMed ID: 8058547
[TBL] [Abstract][Full Text] [Related]
8. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.
George RE; Li S; Medeiros-Nancarrow C; Neuberg D; Marcus K; Shamberger RC; Pulsipher M; Grupp SA; Diller L
J Clin Oncol; 2006 Jun; 24(18):2891-6. PubMed ID: 16782928
[TBL] [Abstract][Full Text] [Related]
9. Thiotepa and melphalan based single, tandem, and triple high dose therapy and autologous stem cell transplantation for high risk neuroblastoma.
Saarinen-Pihkala UM; Hovi L; Koivusalo A; Jahnukainen K; Karikoski R; Sariola H; Wikström S
Pediatr Blood Cancer; 2012 Dec; 59(7):1190-7. PubMed ID: 22492714
[TBL] [Abstract][Full Text] [Related]
10. Disturbances in dental development and craniofacial growth in children treated with hematopoietic stem cell transplantation.
Vesterbacka M; Ringdén O; Remberger M; Huggare J; Dahllöf G
Orthod Craniofac Res; 2012 Feb; 15(1):21-9. PubMed ID: 22264324
[TBL] [Abstract][Full Text] [Related]
11. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant.
Faraci M; Barra S; Cohen A; Lanino E; Grisolia F; Miano M; Foppiano F; Sacco O; Cabria M; De Marco R; Stella G; Dallorso S; Bagnasco F; Vitale V; Dini G; Haupt R
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1568-75. PubMed ID: 15990246
[TBL] [Abstract][Full Text] [Related]
12. Cataracts after autologous bone marrow transplantation in children.
Frisk P; Hagberg H; Mandahl A; Söderberg P; Lönnerholm G
Acta Paediatr; 2000 Jul; 89(7):814-9. PubMed ID: 10943964
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation.
Trahair TN; Vowels MR; Johnston K; Cohn RJ; Russell SJ; Neville KA; Carroll S; Marshall GM
Bone Marrow Transplant; 2007 Oct; 40(8):741-6. PubMed ID: 17724446
[TBL] [Abstract][Full Text] [Related]
14. [Long-term effect of high dose chemotherapy combined with stem cell transplantation on stage IV neuroblastoma in children].
Tang SQ; Huang DS; Wang JW; Feng C; Yang G
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):93-6. PubMed ID: 16613697
[TBL] [Abstract][Full Text] [Related]
15. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
[TBL] [Abstract][Full Text] [Related]
16. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
Fahnehjelm KT; Törnquist AL; Winiarski J
Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
[TBL] [Abstract][Full Text] [Related]
17. Renal function after autologous bone marrow transplantation in children: a long-term prospective study.
Frisk P; Bratteby LE; Carlson K; Lönnerholm G
Bone Marrow Transplant; 2002 Jan; 29(2):129-36. PubMed ID: 11850707
[TBL] [Abstract][Full Text] [Related]
18. Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
Hänel M; Kröger N; Sonnenberg S; Bornhäuser M; Krüger W; Kroschinsky F; Hänel A; Metzner B; Birkmann J; Schmid B; Hoffknecht MM; Fiedler F; Ehninger G; Zander AR
Ann Hematol; 2002 Feb; 81(2):96-102. PubMed ID: 11907790
[TBL] [Abstract][Full Text] [Related]
19. Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients.
Ruiz-Soto R; Sergent G; Gisselbrecht C; Larghero J; Ertault M; Hennequin C; Manson J; de Kerviler E; Briere J; Mounier N
Cancer; 2005 Dec; 104(12):2735-42. PubMed ID: 16284986
[TBL] [Abstract][Full Text] [Related]
20. Microdontia after chemotherapy in a child treated for neuroblastoma.
Remmers D; Bökkerink JP; Katsaros C
Orthod Craniofac Res; 2006 Nov; 9(4):206-10. PubMed ID: 17101028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
